Schedule 13G ownership disclosure
CTI BIOPHARMA CORP
Security class unavailable · CUSIP: 12648L106
Event date: 2016-01-25
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 12,666,354
- Percent of class
- 5.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-16-077753
- Form type
- SC 13G
- Filer
- CTI BIOPHARMA CORP
- CIK
- CIK 891293
- Filed
- Jan 29, 2016
- Reporting period
- Jan 25, 2016
- Description
- Schedule 13G beneficial ownership